IA
RCKT icon

IndexIQ Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

IndexIQ Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$392K Buy
24,715
+15,197
+160% +$263K 0.01% 815
2021
Q4 		$208K Sell
9,518
-615
-6% -$16.8K 0.01% 1027
2021
Q3 		$303K Buy
10,133
+1,015
+11% +$36.9K 0.01% 980
2021
Q2 		$404K Sell
9,118
-142
-2% -$6.17K 0.01% 700
2021
Q1 		$411K Buy
+9,260
New +$508K 0.01% 510

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

IndexIQ Advisors's RCKT Position: Q1 2022 in Review

IndexIQ Advisors increased its Rocket Pharmaceuticals (RCKT) stake by 160% in Q1 2022, buying an estimated $263K and bringing the position to 24,715 shares worth $392K. The position accounts for 0.01% of the portfolio, ranked #815.

IndexIQ Advisors first reported a position in RCKT in Q1 2021 and has held it in 5 quarters since. The position peaked at $411K in Q1 2021. 149 funds tracked by Wall St. Rank hold RCKT as of Q1 2022.

  • IndexIQ Advisors held 24,715 shares of Rocket Pharmaceuticals worth $392K as of Q1 2022.
  • IndexIQ Advisors bought 15,197 Rocket Pharmaceuticals shares in Q1 2022, an estimated $263K.
  • Rocket Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #815 holding.
  • IndexIQ Advisors first reported a position in Rocket Pharmaceuticals in Q1 2021 and has held it in 5 quarters since.
  • IndexIQ Advisors's Rocket Pharmaceuticals position peaked at $411K in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.